Budapest Post

Cum Deo pro Patria et Libertate
Budapest, Europe and world news

Americans should be warned of coronavirus vaccine side effects, medical experts say

Americans should be warned of coronavirus vaccine side effects, medical experts say

Doctors recommended to federal health officials this week that those who eventually receive the long-awaited coronavirus vaccine should be wary of the side effects - such as body aches and bad headaches - so they will return for the second dose. 
While promising coronavirus vaccine candidates could aid in bringing the pandemic to its heels, doctors recommended to federal health officials this week that those who eventually receive the long-awaited jab should be wary of the side effects - such as body aches and bad headaches - so they will return for the second dose.

Medical experts made such recommendations to advisers with the Centers for Disease Control and Prevention (CDC) this week during an online meeting.

Dr. Sandra Fryhofer of the American Medical Association said on Monday during the meeting with the Advisory Committee on Immunization Practices, a group of medical experts that advise the CDC, that the side effects “won’t be a walk in the park.”

“We really need to make patients aware that this is not going to be a walk in the park,” Fryhofer said, CNBC reported. “They are going to know they had a vaccine. They are probably not going to feel wonderful. But they’ve got to come back for that second dose.”

Two promising coronavirus vaccine candidates, created by the pharmaceutical giant Pfizer and the biotechnology company Moderna, respectively, both require two doses. Participants from both clinical trials have reported side effects after receiving the vaccine candidate, neither of which have been approved by the U.S. Food and Drug Administration at this time. (That said, Pfizer, which was the first to announce the results of its vaccine, recently applied for emergency approval for its vaccine from FDA.)

Earlier this month, one Pfizer vaccine candidate told Fox News that the side effects of the shot were "were a little more severe than I thought."

"I had some side effects," Glenn Deshields, a volunteer from Austin, Texas, told “Fox and Friends” at the time. "Basically, I had a headache and a lot of fatigue, injection site pain ... maybe three to four days.”

“The second one, it was similar but it was much more muted. It wasn't as strong. I think I took some Advil and they basically cleared up,” he said.

As for the Moderna vaccine, CEO Stephane Bancel last week, following news that the company’s candidate was more than 90% effective in late-stage clinical trials, discussed the shot’s side effects during an appearance on Fox Business’ “Mornings with Maria” with host Maria Bartiromo.

"The second dose, you have a bit of side effect locally, a bit of pain, a bit of redness, but it goes away by itself,” he said.

"Some people have a bit of a headache," he continued. "It's nice to note that less than 2% of people get a fever, actually 1.4%, so very, very low."

He said the side effects will self-resolve without taking medication.

“It's actually a good thing in my immunologist always reminds me that having a bit of immune reaction is a good signal that your immune system is working because the vaccine is being activated,” Bancel said at the time.

Meanwhile, during the online meeting with the Advisory Committee on Immunization Practices, Patsy Stinchfield, a nurse practitioner at Children’s Minnesota, suggested that public health officials change the language used when warning the public about side effects. She recommended using the word “response” rather than “adverse reaction,” per CNBC.

“These are immune responses,” said Stinchfield. “And so if you feel something after vaccination, you should expect to feel that. When you do, it’s normal to have some arm soreness or fatigue, some body aches and maybe even a fever. It sounds like in some of these trials, maybe even having to stay home from work.”
AI Disclaimer: An advanced artificial intelligence (AI) system generated the content of this page on its own. This innovative technology conducts extensive research from a variety of reliable sources, performs rigorous fact-checking and verification, cleans up and balances biased or manipulated content, and presents a minimal factual summary that is just enough yet essential for you to function as an informed and educated citizen. Please keep in mind, however, that this system is an evolving technology, and as a result, the article may contain accidental inaccuracies or errors. We urge you to help us improve our site by reporting any inaccuracies you find using the "Contact Us" link at the bottom of this page. Your helpful feedback helps us improve our system and deliver more precise content. When you find an article of interest here, please look for the full and extensive coverage of this topic in traditional news sources, as they are written by professional journalists that we try to support, not replace. We appreciate your understanding and assistance.
Newsletter

Related Articles

0:00
0:00
Close
16 Billion Login Credentials Leaked in Unprecedented Cybersecurity Breach
Senate hearing on who was 'really running' Biden White House kicks off
Hungary Ranked Among the World’s Safest Travel Destinations for 2025
G7 Leaders Fail to Reach Consensus on Key Global Issues
FBI and Senate Investigate Allegations of Chinese Plot to Influence the 2020 Election in Biden’s Favor Using Fake U.S. Driver’s Licenses
Trump Demands Iran's Unconditional Surrender Amid Escalating Conflict
Shock Within Iran’s Leadership: Khamenei’s Failed Plan to Launch 1,000 Missiles Against Israel
Wreck of $17 Billion San José Galleon Identified Off Colombia After 300 Years
Man Convicted of Fraud After Booking Over 120 Free Flights Posing as Flight Attendant
Iran Launches Extensive Missile Attack on Israel Following Israeli Strikes on Nuclear Sites
Beata Thunberg Rebrands as Beata Ernman Amidst Sister's Activism Controversy
Hungarian Parliament Approves Citizenship Suspension Law
Prime Minister Orbán Criticizes EU's Ukraine Accession Plans
Hungarian Delicacies Introduced to Japanese Market
Hungary's Industrial Output Rises Amid Battery Sector Slump
President Sulyok Celebrates 15 Years of Hungarian Unity Efforts
Hungary's Szeleczki Shines at World Judo Championships
Visegrád Construction Trends Diverge as Hungary Lags
Hungary Hosts National Quantum Technology Workshop
Hungarian Animation Featured at Annecy Festival
Israel Issues Ultimatum to Iran Over Potential Retaliation and Nuclear Facilities
UK and EU Reach New Economic Agreement
Coinbase CEO Warns Bitcoin Could Supplant US Dollar Amid Mounting National Debt
Trump to Iran: Make a Deal — Sign or Die
Operation "Like a Lion": Israel Strikes Iran in Unprecedented Offensive
Israel Launches 'Operation Rising Lion' Targeting Iranian Nuclear and Military Sites
UK and EU Reach Agreement on Gibraltar's Schengen Integration
Israeli Finance Minister Imposes Banking Penalties on Palestinians
U.S. Inflation Rises to 2.4% in May Amid Trade Tensions
Trump's Policies Prompt Decline in Chinese Student Enrollment in U.S.
Global Oceans Near Record Temperatures as CO₂ Levels Climb
Trump Announces U.S.-China Trade Deal Covering Rare Earths
Smuggled U.S. Fuel Funds Mexican Cartels Amid Crackdown
Austrian School Shooting Leaves Nine Dead in Graz
Bezos's Lavish Venice Wedding Sparks Local Protests
Europe Prepares for Historic Lunar Rover Landing
Italian Parents Seek Therapy Amid Lengthy School Holidays
British Fishing Vessel Seized by France Fined €30,000
Dutch Government Collapses Amid Migration Policy Dispute
UK Commits to 3.5% GDP Defence Spending Under NATO Pressure
Germany Moves to Expedite Migrant Deportations
US Urges UK to Raise Defence Spending to 5% of GDP
Israeli Forces Intercept Gaza-Bound Aid Vessel Carrying Greta Thunberg
IMF Warns of Severe Global Trade War Impacts on Emerging Markets
Low Turnout Jeopardizes Italy's Citizenship Reform Referendum
Transatlantic Interest Rate Divergence Widens as Trump Pressures Powell
EU Lawmaker Calls for Broader Exemptions in Supply Chain Legislation
France's Defense Spending Plans Threatened by High National Debt
European Small-Cap Stocks Outperform U.S. Rivals Amid Growth Revival
Switzerland Proposes $26 Billion Capital Increase for UBS
×